Why is Brawn Biotech falling/rising?

As of 28-Aug, Brawn Biotech Ltd's stock price is currently at Rs 22.83, reflecting an increase of Rs 1.08 or 4.97%. The stock has been on an upward trend, gaining for the last four consecutive days and achieving a remarkable 20.79% return over the past week. Today, it opened with a gain of 4.6% and reached an intraday high of Rs 22.83. Additionally, the stock is trading above its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating strong momentum. However, there has been a slight decline in investor participation, with delivery volume decreasing by 2.45% against the 5-day average, which could suggest some caution among investors.
In the broader market context, Brawn Biotech's performance stands in stark contrast to the Sensex, which has declined by 2.34% over the past week. This significant outperformance of 20.79% compared to the benchmark highlights the stock's strength in a challenging market environment. While the stock has shown positive momentum, the erratic trading pattern and reduced delivery volume may raise concerns about sustainability. Overall, the stock's recent rise can be attributed to strong short-term performance and favorable technical indicators, despite some signs of declining investor engagement.